IDEAS home Printed from https://ideas.repec.org/h/zbw/eschap/276208.html
   My bibliography  Save this book chapter

The Economics and Actors in Vaccine Research and Development

In: From Lab to Jab: Improving Asia and the Pacific’s Readiness to Produce and Deliver Vaccines

Author

Listed:
  • Postigo, Antonio

Abstract

No abstract is available for this item.

Suggested Citation

  • Postigo, Antonio, 2023. "The Economics and Actors in Vaccine Research and Development," EconStor Open Access Book Chapters, in: From Lab to Jab: Improving Asia and the Pacific’s Readiness to Produce and Deliver Vaccines, pages 17-42, ZBW - Leibniz Information Centre for Economics.
    • Handle: RePEc:zbw:eschap:276208
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/276208/1/Postigo-Chapter-2-ADB-2023.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Evenett,Simon J. & Hoekman,Bernard M. & Rocha,Nadia & Ruta,Michele, 2021. "The Covid-19 Vaccine Production Club : Will Value Chains Temper Nationalism?," Policy Research Working Paper Series 9565, The World Bank.
    2. Mark Gersovitz & Jeffrey S. Hammer, 2003. "Infectious Diseases, Public Policy, and the Marriage of Economics and Epidemiology," The World Bank Research Observer, World Bank, vol. 18(2), pages 129-157.
    3. Margherita Balconi & Valeria Lorenzi, 2017. "The increasing role of contract research organizations in the evolution of the biopharmaceutical industry," LEM Papers Series 2017/10, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
    4. Jonathan T. Vu & Benjamin K. Kaplan & Shomesh Chaudhuri & Monique K. Mansoura & Andrew W. Lo, 2020. "Financing Vaccines for Global Health Security," NBER Working Papers 27212, National Bureau of Economic Research, Inc.
    5. Michael Kremer & Christopher M. Snyder, 2015. "Preventives Versus Treatments," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(3), pages 1167-1239.
    6. Patricia Danzon & Nuno Sousa Pereira, 2011. "Vaccine Supply: Effects of Regulation and Competition," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 18(2), pages 239-271.
    7. Christopher S. Hayter & Muhammad Azfar Nisar, 2018. "Spurring Vaccine Development for the Developing World: A Collaborative Governance Perspective on Product Development Partnerships," International Journal of Public Administration, Taylor & Francis Journals, vol. 41(1), pages 46-58, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Joseph P. Newhouse, 2021. "An Ounce of Prevention," Journal of Economic Perspectives, American Economic Association, vol. 35(2), pages 101-118, Spring.
    2. Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
    3. Railey, Ashley F. & Marsh, Thomas L., 2017. "Diagnostic Testing and Vaccine Matching: FMD in Tanzania," 2017 Annual Meeting, July 30-August 1, Chicago, Illinois 258386, Agricultural and Applied Economics Association.
    4. Kremer, Michael & Williams, Heidi & Snyder, Christopher & Goodkin-Gold, Matthew, 2020. "Optimal Subsidies for Prevention of Infectious Disease," CEPR Discussion Papers 15433, C.E.P.R. Discussion Papers.
    5. Byron B. Carson, 2022. "Individuals and Externalities in Economic Epidemiology: A Tension and Synthesis," Journal of Private Enterprise, The Association of Private Enterprise Education, vol. 37(Fall 2022), pages 1-24.
    6. Younes, George Abi & Ayoubi, Charles & Ballester, Omar & Cristelli, Gabriele & de Rassenfosse, Gaetan & Foray, Dominique & Gaule, Patrick & Pellegrino, Gabriele & van den Heuvel, Matthias & Webster, B, 2020. "COVID-19_Insights from Innovation Economists," SocArXiv b5zae, Center for Open Science.
      • Dominique Foray & Gaetan de Rassenfosse & George Abi Younes & Charles Ayoubi & Omar Ballester & Gabriele Cristelli & Matthias van den Heuvel & Ling Zhou & Gabriele Pellegrino & Patrick Gaulé & Elizab, 2020. "COVID-19: Insights from Innovation Economists," Working Papers 10, Chair of Science, Technology, and Innovation Policy.
    7. Zhang, Ying & Andrew, Jane, 2022. "Financialisation and the Conceptual Framework: An update," CRITICAL PERSPECTIVES ON ACCOUNTING, Elsevier, vol. 88(C).
    8. La Torre, Davide & Liuzzi, Danilo & Marsiglio, Simone, 2021. "Epidemics and macroeconomic outcomes: Social distancing intensity and duration," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    9. Kjell Hausken & Mthuli Ncube, 2017. "Policy makers, the international community and the population in the prevention and treatment of diseases: case study on HIV/AIDS," Health Economics Review, Springer, vol. 7(1), pages 1-12, December.
    10. Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," Working Papers 2020-162, Becker Friedman Institute for Research In Economics.
    11. Antonio C. David & Carmen A. Li, 2010. "Exploring the links between HIV|AIDS, social capital and development," Journal of International Development, John Wiley & Sons, Ltd., vol. 22(7), pages 941-961.
    12. Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
    13. Hausken, Kjell & Ncube, Mthuli, 2015. "Policy-Makers, the International Community and People Living with HIV: The Need for New Commitment Mechanisms," UiS Working Papers in Economics and Finance 2015/6, University of Stavanger.
    14. Michal Fabinger & E. Glen Weyl, 2018. "Functional Forms for Tractable Economic Models and the Cost Structure of International Trade," CIRJE F-Series CIRJE-F-1092, CIRJE, Faculty of Economics, University of Tokyo.
    15. Batabyal, Amitrajeet & Beladi, Hamid, 2022. "City and Regional Demand for Vaccines Whose Supply Arises from Competition in a Bertrand Duopoly," MPRA Paper 113758, University Library of Munich, Germany, revised 28 Jun 2022.
    16. Seabright, Paul & Mesnard, Alice, 2008. "Migration and The Equilibrium Prevalence of Infectious Diseases," CEPR Discussion Papers 6651, C.E.P.R. Discussion Papers.
    17. Egger, Peter H. & Masllorens, Gerard & Rocha, Nadia & Ruta, Michele, 2023. "Scarcity nationalism during COVID-19: Identifying the impact on trade costs," Economics Letters, Elsevier, vol. 223(C).
    18. M. Chatib Basri & Lili Yan Ing & Günther G. Schulze, 2022. "Economic Recovery Requires Global Efforts," Chapters, in: Lili Yan Ing & Dani Rodrik (ed.), New Normal, New Technologies, New Financing, chapter 2, pages 8-21, Economic Research Institute for ASEAN and East Asia (ERIA).
    19. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
    20. Eswaran, Mukesh & Gallini, Nancy, 2017. "Can Competition Extend the Golden Age of Antibiotics?," Microeconomics.ca working papers -2017-9, Vancouver School of Economics, revised 19 Oct 2017.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:eschap:276208. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/zbwkide.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.